NCT01235923View on ClinicalTrials.gov

Randomized Study of Weekly Erythropoietin Dosing in Preterm Infants

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

March 31, 2009

Study Completion Date

December 31, 2009

Conditions
Preterm Infants
Interventions
DRUG

three times weekly Epo

Epo 400 units/kg administered subcutaneously three times per week for a total of 4 weeks

DRUG

weekly Epo

Epo 1,200 units/kg administered subcutaneously once a week for a total of 4 weeks

Trial Locations (1)

87131

UNM NICU, Albuquerque

All Listed Sponsors
collaborator

National Center for Research Resources (NCRR)

NIH

lead

University of New Mexico

OTHER

NCT01235923 - Randomized Study of Weekly Erythropoietin Dosing in Preterm Infants | Biotech Hunter | Biotech Hunter